A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed™ Model 6733 125I brachytherapy source

Brachytherapy

Volumn 1, Issue 4, 2002, Pages 227-232

  Sowards, Keith T ^a   Meigooni, Ali S ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

125I; Brachytherapy; Dosimetry; Monte Carlo simulation; TG 43

Indexed keywords

IRIDIUM; IRIDIUM 125; UNCLASSIFIED DRUG; WATER;

ANISOTROPY; ARTICLE; DOSIMETRY; IMPLANT; LIQUID; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 0142258739     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1538-4721(02)00102-2     Document Type: Article

References (16)

1. Hilaris B., Whitmore W., Batata M.et al. Iodine 125 implantation of the prostate. dose-response consideration J.Vaeth Edit Renaissance of interstitial brachytherapy. 1978;82-90 Karger Publish; San Francisco.
2. Blasko J.C., Radge H., Schumacher D. Transperineal percutaneous Iodine 125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Oncology. 3:1987;131-139.
3. Williamson J.F., Coursey B.M., DeWerd L.A.et al. Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources. Med Phys. 25:1998;2269-2270.
4. 125I brachytherapy. Med Phys. 29:2002;939-942.
5. 192Ir seeds. Med Phys. 8:1991;776-785.
6. Williamson J.F. Monte Carlo evaluation of Kerma at a point for photon transport problems. Med Phys. 14:1987;567-576.
7. Williamson J.F. Monte Carlo simulation of photon transport phenomena. Morin R.L. Monte Carlo Simulation in the Radiological Science. 1988;53-102 CRC Press, Boca Raton.
8. Williamson J.F., Perera H., Li Z. Comparison of calculated and measured heterogeneity correction factors for 125I, 137Cs, and 192Ir brachytherapy sources near localized heterogeneities. Med Phys. 20:1993;209-222.
9. Roussin RW, Knight JR, Hubbell JH, et al. Description of the DLC99/HUGO package of photon interaction, Oak Ridge, TN Oak Ridge National Laboratory, RSICC Data Library Collection, Radiation Shielding Center, December, 1983. Report No. ORNL/RSIC-46.
10. Hubbell J.W., Seltzer S.M. Table of X-ray mass atomic attenuation coefficient and mass-energy absorption coefficient 1 keV to 20 MeV foe elements Z=1 to 98 and 48 additional substances of dosimetric interest. 1995;U.S. National Institute of Standards and Technology; Gaithersburg, MD. Report No. NISTIR 5632.
11. National Council on Radiation Protection and Measurements, A handbook of radioactivity measurements procedures. Bethesda, MD: U.S. 1985 Report No. 58.
12. Nath R., Anderson L.L., Luxton G.et al. Dosimetry of interstitial brachytherapy sources. Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 Med Phys. 22:1995;109-134.
13. 125I brachytherapy sources. Med Phys. 15:1988;695-701.
14. 103PD sources. Med Phys. 25:1998;2271-2278.
15. Rivard M.R. Monte Carlo calculations of AAPM Task Group No. 43 dosimetry parameters of the MED3631 A/M 125I source. Med Phys. 28:2001;629-637.
16. Popescu C.C., Wise J., Sowards K.et al. Dosimetric characteristics of the Pharma Seed™ model BT-125-I source. Med Phys. 27:2000;2174-2181.